NASDAQ:BSGM

BioSig Technologies Stock Forecast, Price & News

$4.63

-0.16 (-3.34 %)

(As of 01/25/2021 12:00 AM ET)

Add

Compare

Today's Range

$4.31

Now: $4.63▼

$4.85

50-Day Range

$3.90

MA: $4.58▼

$5.53

52-Week Range

$2.36

Now: $4.63▼

$12.43

Volume243,727 shs

Average Volume498,414 shs

Market Capitalization$142.23 million

P/E RatioN/A

Dividend YieldN/A

Beta1.83

BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.

Overall MarketRank^™

1.57 out of 5 stars

Medical Sector

332nd out of 1,922 stocks

Electromedical Equipment Industry

8th out of 61 stocks

3.5 Analyst's Opinion

Consensus Rating
BioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $9.00, BioSig Technologies has a forecasted upside of 94.4% from its current price of $4.63.
Amount of Analyst Coverage
BioSig Technologies has received no research coverage in the past 90 days.

2.7 Community Rank

Outperform Votes
BioSig Technologies has received 95 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BioSig Technologies has received 79 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
BioSig Technologies has received 54.60% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote “Outperform” if you believe BSGM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
BioSig Technologies does not currently pay a dividend.
Dividend Growth
BioSig Technologies does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BioSig Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $176,427.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 19.49% of the stock of BioSig Technologies is held by insiders.
Percentage Held by Institutions
Only 18.33% of the stock of BioSig Technologies is held by institutions.

0.0 Earnings and Valuation

Price to Book Value per Share Ratio
BioSig Technologies has a P/B Ratio of 8.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:BSGM

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.biosig.com

Phone203-409-5444

Employees33

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio6.83

Quick Ratio6.67

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.53 per share

Price / Book8.74

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-34,060,000.00

Net MarginsN/A

Return on Equity-244.64%

Return on Assets-213.88%

Miscellaneous

Outstanding Shares30,719,000

Market Cap$142.23 million

Next Earnings Date2/4/2021 (Estimated)

OptionableNot Optionable

$4.63

-0.16 (-3.34 %)

(As of 01/25/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions

How has BioSig Technologies' stock been impacted by COVID-19 (Coronavirus)?

BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BSGM stock has increased by 47.5% and is now trading at $4.63.
View which stocks have been most impacted by COVID-19.

Is BioSig Technologies a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BioSig Technologies stock.
View analyst ratings for BioSig Technologies or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than BioSig Technologies?

Wall Street analysts have given BioSig Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BioSig Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is BioSig Technologies' next earnings date?

BioSig Technologies is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for BioSig Technologies.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) posted its quarterly earnings results on Thursday, November, 5th. The company reported ($0.38) earnings per share for the quarter.
View BioSig Technologies' earnings history.

What price target have analysts set for BSGM?

1 Wall Street analysts have issued 1-year target prices for BioSig Technologies' stock. Their forecasts range from $9.00 to $9.00. On average, they expect BioSig Technologies' share price to reach $9.00 in the next year. This suggests a possible upside of 94.4% from the stock's current price.
View analysts' price targets for BioSig Technologies or view Wall Street analyst' top-rated stocks.

Who are some of BioSig Technologies' key competitors?

Some companies that are related to BioSig Technologies include Cutera (CUTR), Stereotaxis (STXS), Edap Tms (EDAP), Soleno Therapeutics (SLNO), electroCore (ECOR), FONAR (FONR), ENDRA Life Sciences (NDRA), Electromed (ELMD), IRIDEX (IRIX), Second Sight Medical Products (EYES), Fc Global Realty (FCRE), ReShape Lifesciences (RSLS), CHF Solutions (CHFS), Helius Medical Technologies (HSDT) and Precision Optics (PEYE).
View all of BSGM's competitors.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the following people:

Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 53, Pay $1.01M)
Mr. Steven Chaussy, Chief Financial Officer (Age 67)
Dr. Budimir S. Drakulic Ph.D., Chief Scientist (Age 71)
Ms. Lora Mikolaitis, VP of Admin. (Age 48)
Mr. Andrew Gornell Ballou, VP of Investor Relations
Mr. John M. Kowalski, VP of Sales
Mr. Olivier Chaudoir, Sr. Director of Marketing
Mr. Todd Wiltshire, Sr. VP of Corp. Devel.
Ms. Natasha Drapeau, Exec. VP

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

How do I buy shares of BioSig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $4.63.

How big of a company is BioSig Technologies?

BioSig Technologies has a market capitalization of $142.23 million. BioSig Technologies employs 33 workers across the globe.

What is BioSig Technologies' official website?

The official website for BioSig Technologies is www.biosig.com.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at 203-409-5444 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here